(Q88142508)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27531824%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Evolving insights in the pathophysiology of complications of cirrhosis: The farnesoid X receptor (FXR) to the rescue? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27531824%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27531824%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Jonel Trebicka

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27531824%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Len Verbeke

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27531824%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

1 reference

30 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27531824%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27531824%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27531824%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27531824%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

1792-1794

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27531824%20AND%20SRC:MED&resulttype=core&format=json

Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions

21 March 2020

cites work

1 reference

7 January 2021

The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats.

1 reference

7 January 2021

Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response

1 reference

7 January 2021

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

1 reference

7 January 2021

Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats

1 reference

7 January 2021

Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression

1 reference

7 January 2021

Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats

1 reference

7 January 2021

FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.28771

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27531824%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference